ArticleFrontiers in pharmacology2017

Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation.

Edmund H Jooste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.